In VivoDevice Transactions Device companies raised a total of $1.2 billion in financing in the fourth quarter, a 16% decrease from Q3's $1.4 billion. Q4 turned out to have the second-lowest financing aggrega
ScripIN VITRO DIAGNOSTICS AltheaDx Inc. AltheaDx 's Series C brings in $30mm AltheaDx Inc. (oncology R&D services and personalized medicine focused on cardio, neuro, and blood disorders) brought in
In VivoNew At The Helm Company Changes AFDHAL , Nezam, MD To: Spring Bank Pharmaceuticals Inc. , CMO (November) From: Consultant Phone: 508-473-5993 BARBOSA , Miguel, PhD To: Mirna Therapeutics In